← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Levosimendan currently has availability issues reported in 3 European registers: Spain, Greece, Sweden.
Shortage ATC C01CX08 · also listed as: LEVOSIMENDAN · data refreshed 14 September 2026
As of 14 September 2026, 3 of the 9 tracked registers list current availability issues for Levosimendan, covering 7 affected product presentations. The longest-running open report was filed in Sweden on 2023-11-29 and has now been open for about 34 months. The furthest expected-resolution date currently on file is 2027-01-31; the earliest is 2026-12-01. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Sweden reported first (2023-11-29), with Greece following roughly 29 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Greece, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Levosimendan is coded C01CX08 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇸 Spain | Shortage LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml + 1 more productsLEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml | 2025-06-25 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability 1 VIAL X 5ML | 2026-04-17 | 2026-12-01 | WIN MEDICA A.E., ΕΛΛΑΔΑ διαδικασία Εναλλακτικά άλλο σκεύασμα της ίδιας Alternatives: APREDONAV F.C.TAB 5MG/TAB BTx56 TABS (σε BLISTER Εναλλακτικά άλλα σκευάσματα της ίδιας δρα | register ↗ |
| 🇸🇪 Sweden | Shortage Levosimendan Amdipharm 2,5 mg/ml Koncentrat till infusionsvätska, lösning + 3 more productsLevosimendan EQL Pharma 2,5 mg/ml Koncentrat till infusionsvätska, lösning Levosimendan Kalceks 2,5 mg/ml Koncentrat till infusionsvätska, lösning Simdax 2,5 mg/ml Koncentrat till infusionsvätska, lösning | 2023-11-29 | 2027-01-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Levosimendan in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Simdax 2,5 mg/ml Koncentrat till infusionsvätska, lösning | Shortage | 2026-06-22 | 2026-07-27 | |
| 🇬🇷 GR | 1 VIAL X 5ML | Limited availability | 2026-04-17 | 2026-12-01 | WIN MEDICA A.E., ΕΛΛΑΔΑ διαδικασία Εναλλακτικά άλλο σκεύασμα |
| 🇪🇸 ES | LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | Shortage | 2025-10-08 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Levosimendan Amdipharm 2,5 mg/ml Koncentrat till infusionsvätska, lösn | Shortage | 2025-07-23 | 2026-08-31 | |
| 🇪🇸 ES | LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIO | Shortage | 2025-06-25 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Levosimendan EQL Pharma 2,5 mg/ml Koncentrat till infusionsvätska, lös | Shortage | 2024-08-07 | 2027-01-31 | |
| 🇸🇪 SE | Levosimendan Kalceks 2,5 mg/ml Koncentrat till infusionsvätska, lösnin | Shortage | 2023-11-29 | 2026-12-25 |
Yes. As of 14 September 2026, availability issues are reported in: Spain, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-01 to 2027-01-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Levosimendan: AEMPS CIMA (Spain), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Levosimendan — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/levosimendan/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Levosimendan availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/levosimendan/">Levosimendan shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>